跳至主要内容
临床试验/CTRI/2017/10/010166
CTRI/2017/10/010166已完成未知

Implementation of a Customized Mobile Application to Improve Medication Adherence and Therapeutic Outcomes in Uncontrolled Diabetic Patients of Tamilnadu

School of Pharmaceutical Sciences Vels University0 个研究点目标入组 690 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
690

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with type II diabetes mellitus on medication with HbA1c greater than 8.0%, willing to provide a written informed consent and come for followup after one and third month.

排除标准

  • Type II diabetic patients with HbA1c less than 8.0%
  • Patients with underlying psychiatric conditions that limit participation.
  • Patients with neurodegenerative diseases including Alzheimer, Parkinsonism and Senile dementia.
  • Patients without access to internet and android devices.
  • Patients who are not willing to provide written informed consent.

研究者

发起方
School of Pharmaceutical Sciences Vels University

相似试验